UK Companies House feature
BESPAK LIMITED
Profile
- Company number
- 15461665
- Status
- Active
- Incorporation
- 2024-02-02
- Last accounts made up
- 2024-12-31
- Account category
- GROUP
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- IFRS
- Reporting scope
- Consolidated (group)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on a going concern basis which the directors consider to be appropriate for the following reasons. The directors have prepared a cash flow forecast for the period to 31 August 2026, (being the going concern review period) which indicates that, taking account of reasonably possible downsides, the group will have sufficient funds to meet its liabilities as they fall due for that period.”
Subsidiaries
- Bespak Europe Limited · 100% held · England · Manufacturing of metered-dose inhaler (MDI) valves and DPIs, including R&D activity
- Bespak HC Limited · 100% held · England · Fill-finish of MDIs and nasal sprays using APIs, including R&D activity
- Bespak Laboratories Inc · 100% held · United States · device development, component manufacturing, fill-finish capabilities, and analytical testing
- Bespak Ventures BV · 100% held · Netherlands · Development of soft mist inhalers (SMIs)
- Resyca 11 BV · 51% held · Netherlands
- Resyca BV · 51% held · Netherlands
- Resyca GmbH · 51% held · Germany
Significant events
- “Bespak Limited was incorporated on 2 February 2024 as a subsidiary within the Roar Holdco AB group. On 1 April 2024, in a re-organisation of the Roar Holdco AB Group, a Group of businesses were transferred under Bespak Limited ("the Group") to create a focused, integrated CDMO for inhalation drug delivery.”
- “On 31 October 2024, it was announced that the US research activities would be moved to the UK, to better serve our customers with an integrated offering effective 31 March 2025.”
- “In July 2025, the Group settled its group relief balances with other UK subsidiaries within the Roar-Holdco group, totalling £31.4 million at 31 December 2024, for cash consideration of £3.4 million, with the remaining £28.0 million waived.”
- “As at 31 December 2024, the immediate parent undertaking and controlling party of Bespak Limited is Roar BidCo AB, a company incorporated in Sweden.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
7 active · 3 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| FAESSLER, Ulrich | Director | 2024-04-01 | Aug 1960 | Swiss |
| HIRST, Christopher Anthony | Director | 2024-04-22 | Apr 1977 | British |
| KLUG, Oren | Director | 2024-04-22 | Sep 1984 | British |
| NEEVE, Maria Louise | Director | 2025-01-14 | May 1974 | British |
| SCHULTZ, Kare | Director | 2024-04-01 | May 1961 | Danish |
| WHITAKER, Anne Michelle Clem | Director | 2024-05-23 | Jun 1967 | American |
| WITTKOWSKI, Matthias | Director | 2024-04-01 | Mar 1983 | German |
Show 3 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BEHAR, Greg | Director | 2024-04-01 | 2025-12-31 |
| HIRST, Christopher Anthony | Director | 2024-02-02 | 2024-04-01 |
| KLUG, Oren | Director | 2024-02-02 | 2024-04-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Eqt Ab | Corporate entity | Shares 75–100%, Voting 75–100% | 2024-02-02 | Active |
Filing timeline
Last 20 of 24 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-04-30 | CH01 | officers | change person director company with change date |
| 2026-04-30 | CH01 | officers | change person director company with change date |
| 2026-02-04 | TM01 | officers | termination director company with name termination date |
| 2025-11-11 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-08-22 | AA | accounts | accounts with accounts type group |
| 2025-07-10 | RP04SH01 | capital | second filing capital allotment shares |
| 2025-07-10 | RP04SH01 | capital | second filing capital allotment shares |
| 2025-06-24 | SH01 | capital | capital allotment shares |
| 2025-03-20 | AP01 | officers | appoint person director company with name date |
| 2025-02-19 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-10-02 | SH01 | capital | capital allotment shares |
| 2024-06-13 | AP01 | officers | appoint person director company with name date |
| 2024-04-25 | AP01 | officers | appoint person director company with name date |
| 2024-04-25 | AP01 | officers | appoint person director company with name date |
| 2024-04-12 | SH01 | capital | capital allotment shares |
| 2024-04-09 | AP01 | officers | appoint person director company with name date |
| 2024-04-09 | TM01 | officers | termination director company with name termination date |
| 2024-04-09 | TM01 | officers | termination director company with name termination date |
| 2024-04-09 | AP01 | officers | appoint person director company with name date |
| 2024-04-09 | AP01 | officers | appoint person director company with name date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory